Pfizer says late-stage trials of its COVID-19 vaccine in children show shots are safe and effective
Pfizer says late-stage trials of its COVID-19 vaccine in children show shots are safe and effective

Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in kids aged between 5 and 11.